卫本医药
卫本医药
Biotech/Healthcare
Hangzhou Weibeng Pharmaceutical Technology Co., Ltd. primarily engages in medical research and experimental development.
Latest round: Angel (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-01-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.